Director Justine Page sold $599K in shares, reducing her directly held stake by 8.4% at a price 24.4% below the 90-day high. This sale is consistent with her 16 prior sells and lacks a strong supporting cluster of buyers, making it a routine diversification event rather than a new signal.

Where it could go — Analyst mean target not provided; bear case if stock breaks the 90-day low of $295.87.

Chief Legal Officer Mark Brazeal sold $9.7M worth of AVGO shares at $387, reducing his directly held stake by 9.3% at a price 21.7% below the 90-day high. This continues his established pattern of regular selling with 18 prior sales totaling over $70M, though the timing near recent lows adds some weight to the bearish signal. Bear: breaks $369 support level.

Where it could go — Broad base rate 41.7% positive at 90d; bull holds $369, bear breaks $369.

Director Henry Samueli sold $250M of AVGO shares, reducing his direct stake by 2.1% at $382.13 per share. This sale continues his pattern of quarterly $120M+ disposals despite the stock trading well below its recent peak.

Where it could go — Analyst mean target implies upside; bear case if stock breaks $369.

Chief Legal Officer Mark Brazeal sold $3.2M worth of AVGO at $389.59, reducing his direct stake by 2.9% at a price 21.3% below the 90-day high. This sale aligns with his historical pattern of 18 prior sales and zero buys, suggesting routine diversification rather than a high-conviction bearish call. Bull: holds $370 support and reclaims $400; bear breaks $370 to test $290 lows.

Where it could go — Broad base rate 41.7% positive at 90d; bull holds $370, bear breaks $370.

Director Harry L. You bought $374K in shares, increasing his stake by 2.7% at a price 24.5% below the recent high. This is his fourth buy on record, but the absence of other recent buyers and the trade's modest scale relative to his history limit its standalone impact.

Where it could go — Analyst mean target not provided; broad pattern base rate is 62.5% positive at 90d.